Infectious cDNA clone of the RA27/3 vaccine strain of Rubella virus.

Rubella virus (RUB), a small plus-strand RNA virus, is a significant human pathogen. The RA27/3 vaccine strain of RUB is one of the most successful live attenuated vaccines developed. In this article, we report the construction of an RA27/3 infectious clone, a complete cDNA copy of the RA27/3 genome that can be transcribed in vitro to generate infectious RNA molecules. Virus generated from such in vitro transcripts was phenotypically similar to RA27/3 virus. To investigate the attenuation of the RA27/3 strain, a series of chimeras was made by the insertion of different fragments of the RA27/3 genome into an infectious clone based on the Therien wild-type strain of RUB. Analysis of the resulting chimeric viruses revealed that the pattern of RA27/3 attenuation in cell culture is complex: attenuating elements in the RA27/3 genome were found in the 5' untranslated region (UTR), a region of the nonstructural proteins containing the protease motif and the capsid gene. Within the 5' UTR, the attenuation determinant was mapped to nt 7. Surprisingly, these analyses also revealed a potentiating mutation at nt 164 of the RA27/3 genome. Although this determinant was within the coding sequences of the nonstructural proteins, the encoded amino acid had no effect on cell culture phenotype and thus the determinant may operate at the level of RNA structure. In addition to investigation of the mechanisms of RA27/3 attenuation, the availability of the RA27/3 infectious clone offers the opportunity for strict genetic control over RUB vaccine manufacturing, for development of novel DNA-based vaccines against RUB, and for development of recombinant RUB vaccines that also target other diseases.

[1]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[2]  J. Chantler,et al.  Mapping of Genetic Determinants of Rubella Virus Associated with Growth in Joint Tissue , 2000, Journal of Virology.

[3]  S. Watowich,et al.  Molecular and biological changes associated with HeLa cell attenuation of wild-type yellow fever virus. , 1999, Virology.

[4]  L. Fan,et al.  Mutations in Sabin 2 strain of poliovirus and stability of attenuation phenotype. , 1999, Virology.

[5]  S. Weaver,et al.  Molecular analysis of rubella virus epidemiology across three continents, North America, Europe, and Asia, 1961-1997. , 1998, The Journal of infectious diseases.

[6]  R. Galler,et al.  Genetic variability among yellow fever virus 17D substrains. , 1998, Vaccine.

[7]  T. Frey,et al.  Effects of Defined Mutations in the 5′ Nontranslated Region of Rubella Virus Genomic RNA on Virus Viability and Macromolecule Synthesis , 1998, Journal of Virology.

[8]  G. Mann,et al.  The yellow fever 17D vaccine virus: molecular basis of viral attenuation and its use as an expression vector. , 1997, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[9]  E. Abernathy,et al.  Improvement of the specific infectivity of the rubella virus (RUB) infectious clone: determinants of cytopathogenicity induced by RUB map to the nonstructural proteins , 1997, Journal of virology.

[10]  J. Meredith,et al.  Role of mutations G-480 and C-6203 in the attenuation phenotype of Sabin type 1 poliovirus , 1995, Journal of virology.

[11]  M. Bouchard,et al.  Determinants of attenuation and temperature sensitivity in the type 1 poliovirus Sabin vaccine , 1995, Journal of virology.

[12]  P. Mason,et al.  Sindbis vectors suppress secretion of subviral particles of Japanese encephalitis virus from mammalian cells infected with SIN-JEV recombinants. , 1995, Virology.

[13]  T. Frey,et al.  Identification of the rubella virus nonstructural proteins. , 1995, Virology.

[14]  T. Frey Molecular Biology of Rubella Virus , 1994, Advances in Virus Research.

[15]  D. Stone,et al.  The 5' noncoding region and virulence of poliovirus vaccine strains. , 1994, Trends in microbiology.

[16]  C. Y. Wang,et al.  Construction of rubella virus genome-length cDNA clones and synthesis of infectious RNA transcripts , 1994, Journal of virology.

[17]  W. T. Moore,et al.  Monoclonal antibody-defined epitope map of expressed rubella virus protein domains , 1991, Journal of virology.

[18]  T. Frey,et al.  Sequence of the genome RNA of rubella virus: Evidence for genetic rearrangement during togavirus evolution☆ , 1990, Virology.

[19]  C. Rice,et al.  Transcription of infectious yellow fever RNA from full-length cDNA templates produced by in vitro ligation. , 1989, The New biologist.

[20]  E. Abernathy,et al.  Genomic sequence of the RAff27/3 vaccine strainof rubella virus , 1997, Archives of Virology.

[21]  U. Carcassi History of hypertrophic osteoarthropathy (HOA). , 1992, Clinical and experimental rheumatology.

[22]  C. Rice,et al.  Infectious enveloped RNA virus antigenic chimeras. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[23]  M. Hemphill,et al.  Time course of virus-specific macromolecular synthesis during rubella virus infection in Vero cells. , 1988, Virology.